|
US3300077A
(en)
|
1965-02-18 |
1967-01-24 |
Clinch Tite Corp |
Pallet enclosure
|
|
DE69027121T3
(de)
|
1989-08-07 |
2001-08-30 |
Peptech Ltd., Dee Why |
Bindeligande für tumornekrosisfaktor
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
WO1993000077A1
(en)
|
1991-06-21 |
1993-01-07 |
University Of Cincinnati |
Orally administrable therapeutic proteins and method of making
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
WO1994025591A1
(en)
|
1993-04-29 |
1994-11-10 |
Unilever N.V. |
PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
|
|
US5512459A
(en)
|
1993-07-20 |
1996-04-30 |
Bionebraska, Inc. |
Enzymatic method for modification or recombinant polypeptides
|
|
ATE234855T1
(de)
|
1993-09-20 |
2003-04-15 |
Anadis Ltd |
Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
BR9813276A
(pt)
|
1997-10-27 |
2000-08-22 |
Unilever Nv |
Proteìna multivalente de ligação de antìgeno, sequências de nucleotìdeos, vetor de expressão, célula hospedeira, processo para preparação de proteìna multivalente de ligação de antìgeno, e, uso da mesma
|
|
EP0954978B1
(en)
|
1998-03-12 |
2011-11-30 |
VHsquared Limited |
New products comprising inactivated yeasts or moulds provided with active antibodies
|
|
WO1999058655A2
(en)
|
1998-05-13 |
1999-11-18 |
Diversys Limited |
Phage display selection system for folded proteins
|
|
AUPP702498A0
(en)
|
1998-11-09 |
1998-12-03 |
Silverbrook Research Pty Ltd |
Image creation method and apparatus (ART77)
|
|
GB9909301D0
(en)
|
1999-04-22 |
1999-06-16 |
Kci Medical Ltd |
Wound treatment apparatus employing reduced pressure
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
BR0116675A
(pt)
|
2000-12-13 |
2003-11-04 |
Unilever Nv |
Método de produção de uma proteìna heteróloga por um fungo e proteìna heteróloga
|
|
AU2002329540A1
(en)
|
2001-06-20 |
2003-01-02 |
Morphosys Ag |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
TWI334439B
(en)
|
2001-08-01 |
2010-12-11 |
Centocor Inc |
Anti-tnf antibodies, compositions, methods and uses
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
|
US20040219142A1
(en)
|
2002-07-19 |
2004-11-04 |
Abbott Laboratories S.A. |
Treatment of skin and nail disorders using TNFalpha inhibitors
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
CA2505316C
(en)
|
2002-11-08 |
2014-08-05 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
WO2004041867A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
|
|
US20060034833A1
(en)
|
2002-11-08 |
2006-02-16 |
Els Beirnaert |
Single domain antibodies directed against interferron-gamma and uses therefor
|
|
ES2655912T3
(es)
|
2002-11-08 |
2018-02-22 |
Ablynx N.V. |
Anticuerpos de dominio simple dirigidos contra factor de necrosis tumoral-alfa y usos para los mismos
|
|
CN1809383A
(zh)
|
2003-04-11 |
2006-07-26 |
免疫医疗公司 |
重组il－9抗体及其用途
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US8007827B2
(en)
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
EP2003276B1
(de)
|
2004-07-14 |
2010-07-14 |
Julius Blum GmbH |
Stellmechanismus für einen schwenkbar gelagerten Stellarm
|
|
MX2007006086A
(es)
|
2004-11-25 |
2007-07-11 |
Unilever Nv |
Anticuerpos de cadena pesada y de dominio.
|
|
US20090087478A1
(en)
|
2004-12-27 |
2009-04-02 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
|
|
US7234616B2
(en)
|
2004-12-27 |
2007-06-26 |
Bel-Art Products, Inc. |
Friction arrangement for hosiery donning aid
|
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
|
MX2007015476A
(es)
|
2005-06-14 |
2008-02-25 |
Amgen Inc |
Formulaciones de proteina autoamortiguadoras.
|
|
US20070042399A1
(en)
|
2005-06-23 |
2007-02-22 |
Imperial College Innovations Limited |
Biological materials and uses thereof
|
|
AU2006265002B2
(en)
|
2005-06-30 |
2012-09-20 |
Centocor, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
|
WO2007025977A2
(en)
|
2005-08-30 |
2007-03-08 |
Actogenix Nv |
Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
|
|
EP3190125A1
(en)
|
2005-08-31 |
2017-07-12 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23 antibodies
|
|
WO2007048022A2
(en)
|
2005-10-21 |
2007-04-26 |
Alexion Pharmaceuticals, Inc. |
Antibody-polypeptide fusion proteins and methods for producing and using same
|
|
CA2634080A1
(en)
|
2005-12-20 |
2007-06-28 |
Arana Therapeutics Limited |
Anti-inflammatory dab
|
|
WO2007104529A2
(en)
|
2006-03-13 |
2007-09-20 |
Ablynx N.V. |
Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
US20080031770A1
(en)
|
2006-08-02 |
2008-02-07 |
Douglas Heselton |
Apparatus and method for using ozone as a disinfectant
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
WO2008031770A2
(en)
|
2006-09-12 |
2008-03-20 |
Cosmo Technologies Ltd |
Pharmaceutical compositions for the oral or rectal administration of protein substances
|
|
US20100129379A1
(en)
|
2006-09-25 |
2010-05-27 |
John Carpenter |
Stabilized antibody formulations and uses thereof
|
|
US8399188B2
(en)
|
2006-09-28 |
2013-03-19 |
Illumina, Inc. |
Compositions and methods for nucleotide sequencing
|
|
US20100129354A1
(en)
|
2006-10-27 |
2010-05-27 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
TW200823720A
(en)
|
2006-11-27 |
2008-06-01 |
Asustek Comp Inc |
Portable computer
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
WO2008075356A2
(en)
|
2006-12-19 |
2008-06-26 |
Shay Bushinsky |
Interactive broadcast system and method
|
|
EP2102244A2
(en)
|
2006-12-19 |
2009-09-23 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
|
TWI317699B
(en)
|
2006-12-25 |
2009-12-01 |
Ind Tech Res Inst |
Device and method for removing residues
|
|
US7459949B2
(en)
|
2007-01-30 |
2008-12-02 |
Mosaid Technologies Incorporated |
Phase detector circuit and method therefor
|
|
JP5966202B2
(ja)
|
2007-02-20 |
2016-08-10 |
アラガン ファーマシューティカルズ インターナショナル リミテッド |
安定な消化酵素組成物
|
|
US20160031971A9
(en)
|
2007-02-20 |
2016-02-04 |
Tufts University |
Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure
|
|
JP2010518839A
(ja)
|
2007-02-21 |
2010-06-03 |
アブリンクス エン．ヴェー． |
血管内皮増殖因子に指向性を有するアミノ酸配列、及び過度の及び／もしくは病的な血管形成又は血管新生を特徴とする症状及び疾患を治療するためにこれを含むポリペプチド
|
|
EP2079456B1
(en)
|
2007-04-04 |
2012-12-05 |
Sigmoid Pharma Limited |
Pharmaceutical cyclosporin compositions
|
|
US7807168B2
(en)
|
2007-04-10 |
2010-10-05 |
Vaccinex, Inc. |
Selection of human TNFα specific antibodies
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
TW201531484A
(zh)
|
2007-05-21 |
2015-08-16 |
Alder Biopharmaceuticals Inc |
抗ＴＮＦ-α之抗體及其用途
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
WO2009021754A2
(en)
|
2007-08-15 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Monospecific and multispecific antibodies and method of use
|
|
TWM333751U
(en)
|
2007-09-07 |
2008-06-01 |
Jarllytec Co Ltd |
Supporting-type pivot structure
|
|
WO2009037264A2
(en)
|
2007-09-17 |
2009-03-26 |
Da Volterra |
Colonic delivery of antimicrobial agents
|
|
EP2725035A1
(en)
|
2007-10-02 |
2014-04-30 |
Avaxia Biologics, Inc. |
Antibody therapy for use in the digestive tract
|
|
EP2214679B1
(en)
|
2007-11-13 |
2019-03-27 |
Meritage Pharma, Inc. |
Corticosteroid compositions
|
|
EP2220120A2
(en)
|
2007-11-27 |
2010-08-25 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
AU2009211370A1
(en)
|
2008-02-07 |
2009-08-13 |
Total Petrochemicals Research Feluy |
Dehydration of alcohols in the presence of an inert component
|
|
KR102057826B1
(ko)
|
2008-04-11 |
2019-12-20 |
추가이 세이야쿠 가부시키가이샤 |
복수 분자의 항원에 반복 결합하는 항원 결합 분자
|
|
AU2009254501B2
(en)
|
2008-06-05 |
2014-07-31 |
Ablynx N.V. |
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
|
|
WO2010018863A1
(ja)
|
2008-08-14 |
2010-02-18 |
日本製紙ケミカル株式会社 |
分散樹脂組成物、それを含有する塗料組成物、インキ組成物、接着剤組成物及びプライマー組成物
|
|
GB0815264D0
(en)
|
2008-08-21 |
2008-09-24 |
Syntaxin Ltd |
Non-cytotoxic proteins
|
|
WO2010045506A2
(en)
|
2008-10-16 |
2010-04-22 |
Kathleen Cogan Farinas |
Sustained drug delivery system
|
|
CA2740301C
(en)
|
2008-10-17 |
2017-02-28 |
Friedrich Streffer |
A method for digesting a biomass comprising lignin together with cellulose and/or hemicellulose
|
|
BRPI0919879A2
(pt)
|
2008-10-29 |
2016-02-16 |
Wyeth Llc |
métodos para purificação de moléculas de ligação a antígeno de domínio único
|
|
EP2362767B1
(en)
|
2008-10-29 |
2017-12-06 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
WO2010085643A1
(en)
*
|
2009-01-22 |
2010-07-29 |
University Of Miami |
Targeting il-7 signaling as a therapy for multiple sclerosis and other il-7 signaling dependent disorders
|
|
NZ595461A
(en)
*
|
2009-04-10 |
2013-01-25 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
|
CN101964403A
(zh)
|
2009-07-23 |
2011-02-02 |
比克国际(天津)有限公司 |
一种电池组的封装方法及电池组
|
|
CN102090373A
(zh)
|
2009-12-11 |
2011-06-15 |
中国医学科学院血液病医院（血液学研究所） |
模拟人克隆氏病的小鼠结肠炎模型及其制备方法和用途
|
|
CL2010000019A1
(es)
|
2010-01-11 |
2010-06-11 |
Univ Chile |
Anticuerpo monoclonal contra el tnf humano y sus fragmentos, secuencias nucleotidicas que lo codifican, vector de expresion y celulas que las contienen, composiciones y kit que comprenden el anticuerpo, uso de los mismos y metodo para su obtencion.
|
|
MX339083B
(es)
|
2010-01-28 |
2016-04-01 |
Glaxo Group Ltd |
Proteinas de enlace a cd127.
|
|
US20130012916A1
(en)
|
2010-02-11 |
2013-01-10 |
Glide Pharmaceutical Technologies Limited |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
AR080291A1
(es)
|
2010-02-24 |
2012-03-28 |
Rinat Neuroscience Corp |
Anticuerpos antagonistas anti receptor de il-7 y procedimientos
|
|
CA2792862C
(en)
|
2010-03-10 |
2018-03-06 |
Incube Labs, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
|
WO2011139629A2
(en)
|
2010-04-26 |
2011-11-10 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
EP2563814A1
(en)
|
2010-04-30 |
2013-03-06 |
Ablynx N.V. |
Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23
|
|
WO2011135040A1
(en)
|
2010-04-30 |
2011-11-03 |
F. Hoffmann-La Roche Ag |
Fluorescent antibody fusion protein, its production and use
|
|
US9024559B2
(en)
|
2010-05-04 |
2015-05-05 |
Johnson Controls Technology Company |
Variable speed drive
|
|
CN108314733A
(zh)
|
2010-07-16 |
2018-07-24 |
埃博灵克斯股份有限公司 |
修饰的单结构域抗原结合分子及其应用
|
|
CA2815888C
(en)
|
2010-10-25 |
2020-06-30 |
National Research Council Of Canada |
Clostridium difficile-specific antibodies and uses thereof
|
|
US9460623B2
(en)
|
2010-11-22 |
2016-10-04 |
International Business Machines Corporation |
Parking management
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
US8566574B2
(en)
|
2010-12-09 |
2013-10-22 |
International Business Machines Corporation |
Secure encrypted boot with simplified firmware update
|
|
US8634563B2
(en)
|
2010-12-17 |
2014-01-21 |
Microsoft Corporation |
Attribute based encryption using lattices
|
|
WO2012132067A1
(ja)
|
2011-03-30 |
2012-10-04 |
中外製薬株式会社 |
抗原結合分子の血漿中滞留性と免疫原性を改変する方法
|
|
ES2688591T3
(es)
|
2011-03-28 |
2018-11-05 |
Ablynx N.V. |
Método para producir formulaciones sólidas que comprenden dominios variables individuales de inmunoglobulina
|
|
CN103547592A
(zh)
|
2011-03-30 |
2014-01-29 |
埃博灵克斯股份有限公司 |
使用针对TNFα的单结构域抗体治疗免疫病症的方法
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
AU2012250924B2
(en)
|
2011-05-02 |
2017-05-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
DK2723769T4
(da)
|
2011-06-23 |
2022-09-05 |
Ablynx Nv |
Teknikker til at forudsige, påvise og reducere uspecifik proteininterferens i assays, som involverer variable immunglobulin-enkeltdomæner
|
|
SG2014010482A
(en)
|
2011-08-17 |
2014-04-28 |
Glaxo Group Ltd |
Modified proteins and peptides
|
|
EP2583980A1
(en)
|
2011-10-19 |
2013-04-24 |
Effimune |
Antibodies directed against the alpha chain of IL7 receptor - their use for the preparation of drug candidates
|
|
CA2852874A1
(en)
|
2011-10-19 |
2013-04-25 |
Alexion Pharma Holding |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
GB2504139B
(en)
|
2012-07-20 |
2014-12-31 |
Argen X Bv |
Antibodies to highly conserved targets produced by the immunisation of Camelidae species
|
|
DE102011121238A1
(de)
|
2011-12-14 |
2013-06-20 |
Universitätsklinikum Hamburg-Eppendorf |
Einzeldomänen-antikörper gegen clostridium difficile toxine
|
|
DE102011121237A1
(de)
|
2011-12-14 |
2013-06-20 |
Universitätsklinikum Hamburg-Eppendorf |
Einzeldomänen-Antikörper gegen Clostridium difficile Toxin CDTa
|
|
WO2013091103A1
(en)
|
2011-12-20 |
2013-06-27 |
Adaerata, Limited Partnership |
Single domain antibodies as inhibitors of pcsk9
|
|
US8874636B2
(en)
|
2012-01-03 |
2014-10-28 |
Teletech Holdings, Inc. |
Method for providing support services using consumer selected specialist and specialist ratings
|
|
NZ701915A
(en)
|
2012-05-18 |
2016-11-25 |
Genentech Inc |
High-concentration monoclonal antibody formulations
|
|
EP2859018B1
(en)
|
2012-06-06 |
2021-09-22 |
Zoetis Services LLC |
Caninized anti-ngf antibodies and methods thereof
|
|
WO2014004746A2
(en)
|
2012-06-26 |
2014-01-03 |
Harvard Bioscience, Inc. |
Methods and compositions for promoting the structural integrity of scaffolds for tissue engineering
|
|
JP2014026709A
(ja)
|
2012-07-30 |
2014-02-06 |
International Business Maschines Corporation |
ライブラリ・ストリング間でのカートリッジの移動方法、システム、及びプログラム
|
|
TWI596115B
(zh)
|
2012-08-13 |
2017-08-21 |
再生元醫藥公司 |
具有ｐＨ－依賴性結合特性之抗－ＰＣＳＫ９抗體
|
|
WO2014030049A2
(en)
|
2012-08-21 |
2014-02-27 |
Glaxo Group Limited |
Compositions comprising a single variable domain and camostat mesylate (cm)
|
|
JP2015534564A
(ja)
|
2012-10-09 |
2015-12-03 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
脱髄障害の治療のための併用療法および使用
|
|
KR101911438B1
(ko)
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
US20140186365A1
(en)
|
2013-01-03 |
2014-07-03 |
Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center |
Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrn
|
|
SG11201507026WA
(en)
|
2013-02-06 |
2015-10-29 |
Anthrogenesis Corp |
Modified t lymphocytes having improved specificity
|
|
JP6541581B2
(ja)
|
2013-03-15 |
2019-07-10 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
低濃度抗体製剤
|
|
WO2015009996A1
(en)
|
2013-07-19 |
2015-01-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating eosinophilic esophagitis
|
|
US20150058173A1
(en)
|
2013-08-20 |
2015-02-26 |
Sears Brands, Llc |
Sales promotion using product comparison
|
|
WO2015058173A1
(en)
|
2013-10-18 |
2015-04-23 |
Abbvie Inc. |
Stable solid units and methods of making the same
|
|
US9416197B2
(en)
|
2013-11-01 |
2016-08-16 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
|
|
WO2015100409A2
(en)
|
2013-12-26 |
2015-07-02 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein
|
|
MX373485B
(es)
|
2014-03-26 |
2020-04-27 |
Cell Medica Switzerland Ag |
Miembros de unión al factor de necrosis tumoral (tnf) alfa.
|
|
EP3142645A4
(en)
|
2014-05-15 |
2017-12-27 |
Rani Therapeutics, LLC |
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
|
|
EP2955196A1
(en)
|
2014-06-10 |
2015-12-16 |
Effimune |
Antibodies directed against CD127
|
|
UA123624C2
(uk)
|
2014-09-03 |
2021-05-05 |
Бьорінґер Інґельхайм Інтернаціональ Ґмбх |
Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
|
|
KR102207381B1
(ko)
|
2014-10-23 |
2021-01-27 |
싱 몰레큘러 메디신, 엘엘씨 |
세포내 항원에 대해 지향된 단일 도메인 항체
|
|
EP3237000A1
(en)
|
2014-12-23 |
2017-11-01 |
Pfizer Inc |
Stable aqueous antibody formulation for anti tnf alpha antibodies
|
|
US20170260266A1
(en)
|
2015-03-11 |
2017-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Tslp binding proteins
|
|
WO2016156468A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptides
|
|
WO2016156474A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptide comprising an immunoglobulin chain variable domain which binds to clostridium difficile toxin a
|
|
DK3277719T3
(da)
|
2015-03-31 |
2022-05-02 |
Sorriso Pharmaceuticals Inc |
Polypeptider
|
|
HK1250011A1
(zh)
|
2015-03-31 |
2018-11-23 |
Sorriso Pharmaceuticals, Inc. |
具有蛋白酶可切割接头的肽构建体
|
|
WO2016156475A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptide comprising an immunoglobulin chain variable domain which binds to clostridium difficile toxin b
|
|
EP3078675A1
(en)
|
2015-04-10 |
2016-10-12 |
Ares Trading S.A. |
Induction dosing regimen for the treatment of tnf alpha mediated disorders
|
|
GB201510758D0
(en)
|
2015-06-18 |
2015-08-05 |
Ucb Biopharma Sprl |
Novel TNFa structure for use in therapy
|
|
EP3405491A1
(en)
|
2016-01-21 |
2018-11-28 |
VHsquared Limited |
Polypeptides
|
|
JP7224917B2
(ja)
|
2016-03-31 |
2023-02-20 |
ソリッソ ファーマシューティカルズ，インク． |
組成物
|
|
EP3519438A1
(en)
|
2016-09-30 |
2019-08-07 |
VHsquared Limited |
Compositions
|
|
DK3551664T3
(da)
|
2016-12-09 |
2021-05-03 |
Ose Immunotherapeutics |
Antistoffer og polypeptider rettet mod cd127
|
|
CA3066053A1
(en)
|
2017-06-04 |
2018-12-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Method of predicting personalized response to cancer treatment with immune checkpoint inhibitors and kits therefor
|
|
AR112341A1
(es)
|
2017-08-02 |
2019-10-16 |
Lilly Co Eli |
ANTICUERPOS BIESPECÍFICOS ANTI-TNF- / ANTI-IL-23 DE IgG
|
|
KR20220063148A
(ko)
|
2019-06-21 |
2022-05-17 |
소리소 파마슈티컬스 인크. |
조성물
|
|
JP7680377B2
(ja)
|
2019-06-21 |
2025-05-20 |
ソリッソ ファーマシューティカルズ，インク． |
ポリペプチド
|
|
WO2020254827A1
(en)
|
2019-06-21 |
2020-12-24 |
Vhsquared Limited |
Polypeptides
|